Novo Nordisk Future Growth
Future criteria checks 4/6
Novo Nordisk is forecast to grow earnings and revenue by 14.4% and 13.1% per annum respectively. EPS is expected to grow by 15% per annum. Return on equity is forecast to be 87.5% in 3 years.
Key information
14.4%
Earnings growth rate
15.0%
EPS growth rate
Pharmaceuticals earnings growth | 15.3% |
Revenue growth rate | 13.1% |
Future return on equity | 87.5% |
Analyst coverage | Good |
Last updated | 17 Oct 2024 |
Recent future growth updates
Recent updates
Novo Nordisk A/S' (CPH:NOVO B) P/E Still Appears To Be Reasonable
Oct 09Is Novo Nordisk (CPH:NOVO B) Using Too Much Debt?
Jul 27Should You Be Adding Novo Nordisk (CPH:NOVO B) To Your Watchlist Today?
Jul 05A Look At The Fair Value Of Novo Nordisk A/S (CPH:NOVO B)
Jun 09Novo Nordisk's (CPH:NOVO B) Promising Earnings May Rest On Soft Foundations
May 09Results: Novo Nordisk A/S Beat Earnings Expectations And Analysts Now Have New Forecasts
May 04The Price Is Right For Novo Nordisk A/S (CPH:NOVO B)
Apr 28Does Novo Nordisk (CPH:NOVO B) Have A Healthy Balance Sheet?
Apr 14Do Novo Nordisk's (CPH:NOVO B) Earnings Warrant Your Attention?
Mar 18Novo Nordisk A/S' (CPH:NOVO B) Price In Tune With Earnings
Dec 30Novo Nordisk (CPH:NOVO B) Seems To Use Debt Rather Sparingly
Dec 12Estimating The Intrinsic Value Of Novo Nordisk A/S (CPH:NOVO B)
Nov 24Calculating The Intrinsic Value Of Novo Nordisk A/S (CPH:NOVO B)
Aug 20Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 402,209 | 148,258 | 118,114 | 163,041 | 21 |
12/31/2025 | 345,069 | 125,940 | 93,691 | 139,928 | 24 |
12/31/2024 | 287,531 | 101,214 | 71,530 | 122,850 | 25 |
6/30/2024 | 258,003 | 89,898 | 66,027 | 115,334 | N/A |
3/31/2024 | 244,243 | 89,276 | 50,304 | 93,408 | N/A |
12/31/2023 | 232,261 | 83,683 | 70,012 | 108,908 | N/A |
9/30/2023 | 214,490 | 75,312 | 77,825 | 106,458 | N/A |
6/30/2023 | 201,325 | 67,239 | 67,497 | 89,731 | N/A |
3/31/2023 | 188,290 | 61,129 | 67,341 | 85,115 | N/A |
12/31/2022 | 176,954 | 55,525 | 64,134 | 78,887 | N/A |
9/30/2022 | 167,195 | 52,825 | 57,875 | 68,769 | N/A |
6/30/2022 | 157,251 | 50,539 | 57,680 | 66,037 | N/A |
3/31/2022 | 149,027 | 49,344 | 59,665 | 67,331 | N/A |
12/31/2021 | 140,800 | 47,757 | 47,615 | 55,000 | N/A |
9/30/2021 | 134,605 | 46,183 | 40,213 | 58,189 | N/A |
6/30/2021 | 129,910 | 44,362 | 31,814 | 54,188 | N/A |
3/31/2021 | 126,875 | 42,864 | 31,337 | 53,194 | N/A |
12/31/2020 | 126,946 | 42,138 | 29,870 | 51,951 | N/A |
9/30/2020 | 127,225 | 41,537 | 44,800 | 56,944 | N/A |
6/30/2020 | 126,575 | 41,433 | 47,621 | 56,126 | N/A |
3/31/2020 | 126,605 | 40,403 | 36,987 | 46,904 | N/A |
12/31/2019 | 122,021 | 38,951 | 35,551 | 46,782 | N/A |
9/30/2019 | 119,336 | 38,731 | 36,785 | 49,029 | N/A |
6/30/2019 | 116,821 | 37,574 | 31,251 | 43,960 | N/A |
3/31/2019 | 114,192 | 38,322 | 32,202 | 44,691 | N/A |
12/31/2018 | 111,831 | 38,628 | 32,206 | 44,616 | N/A |
9/30/2018 | 110,091 | 38,384 | 31,576 | 43,236 | N/A |
6/30/2018 | 108,943 | 39,117 | 33,787 | 44,538 | N/A |
3/31/2018 | 110,174 | 38,725 | N/A | 38,885 | N/A |
12/31/2017 | 111,696 | 38,130 | N/A | 41,168 | N/A |
9/30/2017 | 113,276 | 38,576 | N/A | 46,289 | N/A |
6/30/2017 | 114,199 | 38,609 | N/A | 48,557 | N/A |
3/31/2017 | 113,020 | 38,626 | N/A | 52,937 | N/A |
12/31/2016 | 111,780 | 37,925 | N/A | 48,314 | N/A |
9/30/2016 | 111,084 | 37,484 | N/A | 47,280 | N/A |
6/30/2016 | 110,339 | 36,064 | N/A | 44,179 | N/A |
3/31/2016 | 109,939 | 34,439 | N/A | 41,656 | N/A |
12/31/2015 | 107,927 | 34,860 | N/A | 38,287 | N/A |
9/30/2015 | 103,636 | 33,131 | N/A | 35,469 | N/A |
6/30/2015 | 99,093 | 31,248 | N/A | 35,578 | N/A |
3/31/2015 | 93,663 | 29,899 | N/A | 31,729 | N/A |
12/31/2014 | 88,806 | 26,481 | N/A | 31,692 | N/A |
9/30/2014 | 85,919 | 26,005 | N/A | 29,763 | N/A |
6/30/2014 | 84,181 | 25,920 | N/A | 23,783 | N/A |
3/31/2014 | 83,932 | 25,660 | N/A | 22,941 | N/A |
12/31/2013 | 83,572 | 25,184 | N/A | 25,942 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NOVO B's forecast earnings growth (14.4% per year) is above the savings rate (1%).
Earnings vs Market: NOVO B's earnings (14.4% per year) are forecast to grow faster than the Danish market (14.1% per year).
High Growth Earnings: NOVO B's earnings are forecast to grow, but not significantly.
Revenue vs Market: NOVO B's revenue (13.1% per year) is forecast to grow faster than the Danish market (10.4% per year).
High Growth Revenue: NOVO B's revenue (13.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: NOVO B's Return on Equity is forecast to be very high in 3 years time (87.5%).